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Dr Charles Fraser (Houston, Tex). I congratulate Dr Sood and
colleagues from Nemours Cardiac Center for this body of work
adding further information to this ongoing and sometimes curious
debate about the benefits of NIRS in providing relevant periopera-
tive physiologic monitoring and potentially optimizing ND out-
comes in children with critical cardiac disease undergoing surgery.
Without attempting to resummarize this well-written manu-
script and elegant presentation that we’ve just heard, I synopsize444 The Journal of Thoracic and Cardiovascular Surgthis work as follows: In a heterogeneous group of 31 children un-
dergoing repair in infancy, 8 of whom had single ventricles, using
various CPB strategies but a lot of circulatory arrest, you’ve ob-
served and concluded that perioperative NIRS monitoring has pre-
dictive utility in ultimate ND outcome. Specific observations
included noting that a 52% decrease from baseline IO NIRS satu-
ration correctly classified 75% of children with receptive commu-
nication delay and that a PO threshold of 56% correctly classified
100% of children with cognitive delay.
As the authors probably know, these data are somewhat consis-
tent with ours from Texas Children’s Hospital as recently pre-
sented at the Society of Thoracic Surgeons meeting in Florida
by my colleague Dean Andropoulos. We presented there and
will soon report in print our findings that low perioperative cere-
bral cortical oxygen saturations as measured by NIRS has a direct
relationship with 12-month Bayley developmental scores. To our
view, and apparently now yours, measuring oxygen delivery to
the brain has clinical relevance in predicting outcome.
You note that 94% of the children had circulatory arrest. Other
than the isolated measured data points documenting the lowest IO
saturations, were you able to measure the total time spent at nadir?
We should probably ask the same questions about preoperative and
PO levels.
Dr Sood. We did not measure total time spent at nadir. This
study examined NIRS data collected using the prior software,
which did not report AUC. Also, we obtained PO NIRS data
from the medical record, which were entered on an hourly basis.
However, we examined total time spent below specific NIRS
thresholds in our prior study of IO NIRS and did not find an asso-
ciation with ND outcomes. Kussman and colleagues9 examined
the relationship between IO NIRS data and ND outcomes at 1
year of age and did not find an association between AUC for
rSO2 less than or equal to 45% and ND outcomes. But certainly
this needs to be further examined in future studies.
Dr Fraser.Well, that’s a good segue into question 2. Your group
has published 3 related abstracts on this subject in the last 4
months. In the January issue of the Journal you concluded, and I
quote: ‘‘In a contemporary cohort of infants undergoing surgery
for congenital heart disease, neurodevelopmental outcomes at 2
years are largely influenced by patient-related characteristics. Al-
though receptive communication appears to be influenced by the
NIRS nadir, the predictive value remains unclear.’’
Elsewhere in this meeting’s program, there is a poster abstract in
which you conclude, apparently in the same group of patients, that
‘‘duration of hypothermic circulatory arrest was not predictive of
any neurodevelopmental outcome.’’
Finally, in this article you conclude, ‘‘NIRS monitoring during
and beyond the IO period seems to enhance the ability to predict
ND outcomes at 2 years of age.’’ So please help me tie this all
together.
Dr Sood. Our recent article in the Journal reported on only IO
data, and the results were generally consistent with what was found
in the present study. The prior study found a relationship between
IO NIRS nadir and receptive communication outcome, and the
present study found a relationship between IO percent decrease
from baseline and receptive communication outcome. The rela-
tionship that we previously described between IO NIRS nadir
and receptive communication did not reach statistical significanceery c February 2013
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Din the present sample. However, receptive communication was the
domain associated with NIRS data in both studies.
Although the study samples for the 3 abstracts that you referred
to do overlap, they are not equivalent samples. Additional patients
have been tested since the 2 prior abstracts, and the specific inclu-
sion criteria differ across studies. For example, several patients in-
cluded in the IO NIRS study were excluded from this study
because perioperative NIRS data were not available.
Dr Christian Pizarro (Wilmington, Del). Maybe I could help
with that answer. I think that last year when we presented some
of these data at the meeting in Philadelphia, the question was
raised to the fact that there were no PO data, and obviously things
could occur in that immediate period, particularly in the first 48
hours, and that was the stimulus for us to go back and try to obtain
and look at the PO data and NIRS monitoring.
Now, the challengewas that not every patient had PONIRS data
available, and therefore that’s why there is a slight difference in
which patients were included in each study. But the idea for this
particular project was to look at all patients who had NIRS data
available before, during, and after surgery.
Dr Fraser. Christian might want to comment on this as well. In
the last sentence of your conclusion in the article you state that
‘‘Further research is needed to investigate these relationships in
a prospective manner and to examine whether goal-directed ther-
apy can alter NIRS measurements and long-term ND outcomes.’’
As we talked about earlier, first, you can alter NIRS measure-
ments with direct interventions (eg, higher hematocrit, higher
flow rates). On the basis of what you’ve learned so far, do you
plan to change your strategy going forward and act on the NIRS
information rather than just observe it?
Dr Pizarro. That’s a great question. Part of the challenge is the
fact that when it comes to IO interventions, obviously the intuitive
mode of treatment would be to alter perfusion, for example, use re-
gional antegrade cerebral perfusion; however, we do not know the
true impact of this strategy that may increase cerebral edema, for
example. This is different than increasing the hematocrit in theThe Journal of Thoracic and Caintensive care unit or giving inotropes and trying to augment car-
diac output by other means. So as stated before, CPB is probably
an unnatural state, and there is some potential morbidity from it.
If we look at the Michigan study where randomization of
regional cerebral perfusion and circulatory arrest was undertaken,
actually no difference was demonstrated. Although we could alter
the number that the NIRS monitor gives us, the consequences and
the impact of the measures that we used to achieve that might not
necessarily improve the overall outcome. What we discovered
through this analysis is that it seems like the cutoff, of 40% as
a nadir, might be too low, and data would suggest that perhaps
the cutoff is in the 50s.Wewould be inclined to continue to explore
this, enroll more patients to include in the analysis, and probably, if
the data sustain the study’s findings, modify our approach to it.
Dr J. William Gaynor (Philadelphia, Pa). I agree with your fi-
nal statement. We have to be careful about using historical con-
trols. This is an important first step, along with the data from
Texas Children’s, that we’re beginning to get data that may corre-
late some of these measurements at certain time points, and partic-
ularly in the PO period, with ND outcomes. These type of data will
be important, although it take some time before it becomes com-
pletely ingrained in clinical practice.
We recently did a systematic review of the literature for many of
the things that we do for neuroprotection and neuromonitoring,
and the level of evidence for what we do is appalling. There is
almost nothing that reaches class 1 evidence. We have an opportu-
nity if people will be willing to design appropriate trials, based on
this type of evidence, to begin to look at NIRS in a formal prospec-
tive way with evaluation of goal-directed therapy.
Some of the work by Dr Licht has suggested that increasing de-
livery may not be the best thing. Perhaps we have to decrease de-
mand, for example, keeping patients intubated or sedated longer,
perhaps cooling a little bit. I don’t know. If we begin to have
some idea of the balance between oxygen use and oxygen delivery,
then we should design a trial, so going forward we actually have
evidence for some of the things we do.rdiovascular Surgery c Volume 145, Number 2 445
